Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Modeling valuations for EuroQol health states.

Dolan P.

Med Care. 1997 Nov;35(11):1095-108.

PMID:
9366889
2.
3.

Aggregating health state valuations.

Dolan P.

J Health Serv Res Policy. 1997 Jul;2(3):160-5; discussion 166-7.

PMID:
10180377
4.

Modelling valuations for health states: the effect of duration.

Dolan P.

Health Policy. 1996 Dec;38(3):189-203.

PMID:
10162421
5.
6.

[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].

Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ.

Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1574-8. Dutch.

PMID:
16038162
7.

A social preference valuations set for EQ-5D health states in Flanders, Belgium.

Cleemput I.

Eur J Health Econ. 2010 Apr;11(2):205-13. doi: 10.1007/s10198-009-0167-0. Epub 2009 Jul 7.

PMID:
19582490
8.

A comparison of scoring weights for the EuroQol derived from patients and the general public.

Polsky D, Willke RJ, Scott K, Schulman KA, Glick HA.

Health Econ. 2001 Jan;10(1):27-37.

PMID:
11180567
9.

South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states.

Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, Kind P, Kweon SS, Kim YT.

Value Health. 2009 Nov-Dec;12(8):1187-93. doi: 10.1111/j.1524-4733.2009.00579.x. Epub 2009 Jul 29.

10.

Time preference, duration and health state valuations.

Dolan P, Gudex C.

Health Econ. 1995 Jul-Aug;4(4):289-99.

PMID:
8528431
11.

Quantification of health states with rank-based nonmetric multidimensional scaling.

Krabbe PF, Salomon JA, Murray CJ.

Med Decis Making. 2007 Jul-Aug;27(4):395-405.

PMID:
17761959
12.

Health state valuations from the general public using the visual analogue scale.

Gudex C, Dolan P, Kind P, Williams A.

Qual Life Res. 1996 Dec;5(6):521-31.

PMID:
8993098
13.

The comparability and reliability of five health-state valuation methods.

Krabbe PF, Essink-Bot ML, Bonsel GJ.

Soc Sci Med. 1997 Dec;45(11):1641-52.

PMID:
9428084
15.

Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.

Mukuria C, Rowen D, Brazier JE, Young TA, Nafees B.

Value Health. 2015 Sep;18(6):846-55. doi: 10.1016/j.jval.2015.07.004. Epub 2015 Aug 24.

16.

The impact of adding an extra dimension to a preference-based measure.

Brazier J, Rowen D, Tsuchiya A, Yang Y, Young TA.

Soc Sci Med. 2011 Jul;73(2):245-53. doi: 10.1016/j.socscimed.2011.05.026. Epub 2011 Jun 2.

17.

Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population.

Mulhern B, Rowen D, Snape D, Jacoby A, Marson T, Hughes D, Baker G, Brazier J.

Epilepsy Behav. 2014 Jul;36:12-7. doi: 10.1016/j.yebeh.2014.04.011. Epub 2014 May 16.

PMID:
24836527
19.

Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.

Zarate V, Kind P, Chuang LH.

Value Health. 2008 Dec;11(7):1170-7. doi: 10.1111/j.1524-4733.2008.00349.x. Epub 2008 May 16.

20.

Valuing health states: a comparison of methods.

Dolan P, Gudex C, Kind P, Williams A.

J Health Econ. 1996 Apr;15(2):209-31.

PMID:
10159110

Supplemental Content

Support Center